- Home
- JOF vs OCGN Comparison
JOF vs OCGN Comparison
Compare JOF & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOF
- OCGN
- Stock Information
- Founded
- JOF 1990
- OCGN 2013
- Country
- JOF Japan
- OCGN United States
- Employees
- JOF N/A
- OCGN N/A
- Industry
- JOF Trusts Except Educational Religious and Charitable
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JOF Finance
- OCGN Health Care
- Exchange
- JOF Nasdaq
- OCGN Nasdaq
- Market Cap
- JOF 278.2M
- OCGN 283.3M
- IPO Year
- JOF N/A
- OCGN N/A
- Fundamental
- Price
- JOF $9.70
- OCGN $0.99
- Analyst Decision
- JOF
- OCGN Strong Buy
- Analyst Count
- JOF 0
- OCGN 3
- Target Price
- JOF N/A
- OCGN $6.00
- AVG Volume (30 Days)
- JOF 43.9K
- OCGN 3.7M
- Earning Date
- JOF 01-01-0001
- OCGN 08-01-2025
- Dividend Yield
- JOF 3.33%
- OCGN N/A
- EPS Growth
- JOF N/A
- OCGN N/A
- EPS
- JOF N/A
- OCGN N/A
- Revenue
- JOF N/A
- OCGN $4,754,000.00
- Revenue This Year
- JOF N/A
- OCGN N/A
- Revenue Next Year
- JOF N/A
- OCGN N/A
- P/E Ratio
- JOF N/A
- OCGN N/A
- Revenue Growth
- JOF N/A
- OCGN N/A
- 52 Week Low
- JOF $6.64
- OCGN $0.52
- 52 Week High
- JOF $8.04
- OCGN $1.42
- Technical
- Relative Strength Index (RSI)
- JOF 52.13
- OCGN 45.53
- Support Level
- JOF $9.64
- OCGN $1.01
- Resistance Level
- JOF $9.79
- OCGN $1.11
- Average True Range (ATR)
- JOF 0.11
- OCGN 0.07
- MACD
- JOF -0.02
- OCGN -0.01
- Stochastic Oscillator
- JOF 39.78
- OCGN 21.52
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").